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Introduction: The ability of Streptococcus thermophilus to convert lactose into lactic acid has
long been utilized by the dairy industry. A seemingly low-pathogenicity organism, to the best of
our knowledge there have been no previously published reports linking the consumption of
foodstuffs to bacteraemia caused by this bacterium.
Case presentation: Here we present a case of a regular consumer of Activia yoghurt who
developed S. thermophilus bacteraemia, probably due to transient bowel ischaemia secondary
to polycythaemia.
Conclusion: The isolation of this bacterium from blood cultures may indicate underlying large
bowel pathology and should not necessarily be dismissed as contamination.
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Introduction
Infection secondary to the consumption of probiotic pro-
ducts is a safety concern, but despite the widespread
consumption of these products, reports of infections by pro-
biotic organisms are extremely rare. A previous literature
review identified 15 reports of infection associated with the
consumption of products containing probiotic organisms,
none of which mention Streptococcus thermophilus as a cause.
S. thermophilus (previously known as Streptococcus salivar-
ius subsp. thermophilus) is a Gram-positive, a-haemolytic
bacterium that is ubiquitous in the dairy industry. Classi-
fied as a ‘lactic acid bacterium’, the organism’s ability to
convert lactose to lactic acid is harnessed in the manufac-
ture of a number of dairy products such as yoghurts and
cheeses. It is regarded as a low-pathogenicity organism,
as genomic studies have shown that common streptococcal
virulence genes are either absent or switched off in
this species (Prajapati et al., 2013). It also has ‘Qualified
Presumption of Safety’ status in the European Union, as
there is a long history of safe use in the food industry
(Iyer et al., 2010). In fact, it is thought that over 1|1021
live S. thermophilus bacteria are consumed every year
around the world (Hols et al., 2005).
The current case, an immunocompetent patient with inter-
current transient bowel ischaemia on a background of
secondary polycythaemia, represents the first reported
case, to the best of our knowledge, of bacteraemia due to
S. thermophilus.
Case report
An 86-year-old lady presented to the Accident and Emer-
gency Department at Nottingham University Hospitals
NHS Trust, with a 4 h history of right-sided lower abdomi-
nal pain and anorexia. The pain was colicky in nature
and rated as 8/10 on a pain scale. She had no nausea or
vomiting, no urinary tract symptoms and her bowels were
functioning normally. Her past medical history included
early-onset Alzheimer’s disease, polycythaemia secondary
to ischaemic heart disease (JAC2 mutation negative), atrial
fibrillation, hypertension and peripheral vascular disease.
Her drug history included digoxin, bisoprolol, enalapril,
co-amilofruse, simvastatin, aspirin and amitriptyline. She
lived with her son who was her full-time carer. On examin-
ation, her temperature was 38.4 uC, heart rate was 88 beats
min21 and blood pressure was 135/84 mmHg. On chest aus-
cultation, breath and heart soundswere normal and nomur-
murs were audible. Her abdomen was diffusely tender with
more severe tenderness and guarding in the right iliac
fossa. The differential diagnosis included acute appendicitis,
diverticulitis and acute bowel ischaemia.
Investigations
An erect chest radiograph was performed, which showed
no air under the diaphragm. An abdominal radiograph
was also undertaken, which showed no signs of bowel
obstruction. A full blood count showed a raised white
cell count of 12.3|109 l21 with a neutrophilia (9.8|109
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l21) and haemoglobin of 179 g l21. Her lactate level was
1.8 mmol l21. Renal and liver function tests were unre-
markable. A urine dipstick was negative for nitrites and
leukocytes. Two sets of blood cultures were obtained and
incubated in a BACTEC FX blood-culture system (BD
Diagnostic Systems). She was referred to the surgical
team and empirical therapy with piperacillin/tazobactam
4.5 g every 8 h intravenously was initiated. The following
day, she underwent a computed tomography scan of the
abdomen, which showed no radiological features of acute
appendicitis or diverticulitis. Taken together, the clinical
presentation and investigations suggested that bowel
ischaemia was the most likely diagnosis. Her abdominal
pain and fever resolved completely with conservative man-
agement, and she was discharged later the same day with a
5-day course of co-amoxiclav 250/125 mg every 8 h orally.
The day after discharge, both the aerobic and anaerobic
bottles from one of the two sets of blood cultures taken
on admission signalled as positive (after 16 h of incu-
bation) and Gram-stained smears from both bottles
showed Gram-positive cocci in chains (Fig. 1). After 24 h
of incubation in 5% CO2, small, grey, a-haemolytic colo-
nies were visible on 5% horse blood agar (Fig. 2).
A catalase test reaction and bile aesculin were negative,
and the organism was presumptively identified as belong-
ing to the ‘viridans streptococci’ group. The organism
was further identified as S. thermophilus using a VITEK -
system (bioMe´rieux), and this was subsequently confirmed
by 16S rRNA gene sequencing (Molecular Identification
Services Unit; Public Health England, UK). The organism
was sensitive to amoxicillin using British Society for Anti-
microbial Chemotherapy antimicrobial susceptibility
methodology. Upon further questioning of the patient’s
son, it became apparent that she regularly consumed Acti-
via yoghurt (The Danone Company).
Outcome and follow-up
On review, following the identification of S. thermophilus
in the blood culture, the patient remained asymptomatic.
The 5-day course of co-amoxiclav was completed.
No further blood cultures were obtained. On review
6 months following discharge, she had had no further epi-
sodes of abdominal pain or fever.
Discussion
For centuries, people have knowingly ingested dairy pro-
ducts containing bacteria due to perceived health benefits.
A probiotic is defined as ‘live micro-organisms that when
ingested in large enough quantities confer a health benefit
on the host’ (Fuller, 1991). The most commonly used bac-
teria in probiotics are species from the genera Streptococ-
cus, Lactobacillus and Bifidobacterium. The probiotic used
by the patient in this case was the yoghurt Activia (The
Danone Company), which contains S. thermophilus, Lacto-
bacillus bulgaris and Bifidobacterium lactis. A number of
claims have been made concerning the benefits of probiotic
products to the consumer’s health, from promises of
improved ‘gastrointestinal health’ to the lowering of
serum cholesterol levels. Over recent years, the study of
probiotics and their effect on health has been substantial.
Athough there has been much research, there is little evi-
dence to show that probiotics do in fact confer significant
health benefits. However, one area in which probiotics do
appear to be beneficial is in the treatment of diarrhoea.
A recent meta-analysis looked at the effect of probiotics
on antibiotic-associated diarrhoea and found that they
did have a protective effect (D’Souza et al., 2002). The
effect of probiotics on acute infectious diarrhoea has also
been subjected to meta-analysis, which also demonstrated
a beneficial effect (Sazawal et al., 2006).
Fig. 1. Gram stain of S. thermophilus from broth culture after
16 h incubation.
Fig. 2. Colonies of S. thermophilus on 5 % horse blood agar
after 24 h incubation in 5 % CO2.
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An obvious issue with ingestion of live micro-organisms
is the assurance of safety. Probiotics should not cause infec-
tion in the consumer. This may be more of a risk in
certain situations such as this case (transient ischaemia
allowing translocation), those with damaged intestinal
integrity secondary to chemotherapy or radiotherapy,
infants with an immature intestinal barrier and those with
an immunocompromised immune system. There have
been a number of case reports of patients developing bacter-
aemia, whichwere thought to be secondary to probiotic con-
sumption (Boyle et al., 2006). To the best of our knowledge,
there have been no previous reports of bacteraemia with
S. thermophilus associated with probiotic consumption.
As an a-haemolytic streptococcus, S. thermophilus in a
single blood culture may easily be dismissed as a mere
contaminant (and may not be identified to the species
level in all cases), particularly if the patient is not displaying
overt signs of sepsis. There are also reports of difficulty
confirming the identification of S. thermophilus by 16S
rRNA gene sequencing alone (Wilck et al., 2001) or
matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry fingerprinting (Christner et al., 2010).
We hypothesize that consuming Activia yoghurt on a
regular basis caused S. thermophilus to become part of this
patient’s large intestinal microbiota. Transient bowel ischae-
mia, which was likely to be secondary to polycythaemia,
probably permitted the organism to translocate and enter
the bloodstream.
When one considers the sheer volume of probiotic products
consumed around theworld, and the possibility of large intes-
tinal colonization, transient bacteraemiawith various probio-
tic organisms is likely tooccur onoccasion due to intercurrent
pathology of the large intestine. We would like to emphasize
that this case does not signify safety issues with probiotic pro-
ducts containing S. thermophilus; indeed, colonization of the
large intestine with S. thermophilus (and other probiotic
organisms) might protect against translocation-related bac-
teraemia due to more pathogenic organisms (Sahin et al.,
2012). Clinical microbiologists should, however, be aware of
this organismand consider the possibility of large bowel path-
ology rather than contamination if it is identified in blood-
culture specimens.
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